- In March 2024, Cryo-Cell announced the spin-off of Celle Corp. (its subsidiary) to maximize shareholder value
- In September 2024, Global Cord Blood Corporation announced that it would acquire Cellenkos, Inc. It was expected to be a 100% acquisition along with the rights to develop & commercialize its future and existing products except for the products related to Cellenkos’s existing collaboration with Incyte Corporation
